Aurum PropTech Limited — Capital/Financing Update 2023

Feb 10, 2023

==> picture [452 x 64] intentionally omitted <==

Date: 10.02.2023

To, Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Fort, Bandra East, Mumbai – 400 001 Mumbai – 400 051

BSE Scrip Code: 539289 NSE Symbol: AURUM

Sub: Monitoring Agency Report for the quarter ended December 31, 2022 - in relation to the Rights Issue of Aurum PropTech Limited (“the Company”).

Dear Sir/ Madam,

Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 82(2) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find attached Monitoring Agency Report for the quarter ended December 31, 2022, issued by Care Ratings Ltd., Monitoring Agency, appointed to monitor the utilisation of proceeds of the Rights Issue of the Company.

You are requested to take the same on record.

Thanking you.

Yours faithfully,

For Aurum PropTech Limited

SONIA Digitally signed by SONIA HITESH HITESH JAIN Date: 2023.02.10 JAIN 12:36:43 +05'30' Sonia Jain Company Secretary

Encl: as above

==> picture [560 x 83] intentionally omitted <==

==> picture [137 x 39] intentionally omitted <==

No. CARE/DRO/GEN/2022-23/1026

Shri Kunal Karan Chief Financial Officer

Aurum Proptech Limited

Gen-4/1, Aurum Building Q1, TTC Industrial Area Thane - Belapur Rd, Ghansoli, Navi Mumbai, Maharashtra 400710

January 20, 2023

Dear Sir,

Monitoring Agency Report for the quarter ended December 31, 2022 - in relation to the Public Issue of

We write in our capacity of Monitoring Agency for the Public Issue for the amount aggregating to Rs. 343.56 crore of the Company and refer to our duties cast under 82 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.

In this connection, we are enclosing the Monitoring Agency Report for the quarter ended December 31, 2022 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated April 8, 2022.

Request you to kindly take the same on records.

Thanking you,

Yours faithfully,

==> picture [125 x 35] intentionally omitted <==

Sachin Mathur

Assistant Director

Sachin.mathur@careedge.in

CARE Ratings Limited

E-1, 13th Floor, Videocon Tower, Jhandewalan Extension, New 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Delhi 110055 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-011-4533 3200 / 238 Phone: +91-22-6754 3456 Email:

==> picture [124 x 173] intentionally omitted <==

CIN-L67190MH1993PLC071691

Report of the Monitoring Agency (MA)

Name of the issuer: Aurum PropTech Limited For quarter ended: December 31, 2022 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not applicable

Declaration:

We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013.

The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.

We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed

==> picture [124 x 34] intentionally omitted <==

Signature: Name of the Authorized Signatory: Sachin Mathur Designation of Authorized person/Signing Authority: Assistant Director

CARE Ratings Limited

==> picture [124 x 173] intentionally omitted <==

E-1, 13th Floor, Videocon Tower, Jhandewalan Extension, New 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Delhi 110055 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-011-4533 3200 / 238 Phone: +91-22-6754 3456 Email:

CIN-L67190MH1993PLC071691

1) Issuer Details: Name of the issuer Name of the promoter Private Limited) Industry/sector to which it belongs

: Aurum Proptech Limited : Aurum Real Estate Developers Limited (formerly Aurum Platz IT

: Information Technology and IT enabled services.

2) Issue Details Issue Period : April 26, 2022 to May 10, 2022 Type of issue (public/rights) : Rights issue Type of specified securities : Equity shares IPO Grading, if any : Not applicable Issue size (in `crore) : Rs. 343.56 crore (Note 1)*

==> picture [489 x 72] intentionally omitted <==

Note 1:

Particulars	Remarks
Total shares issued and subscribed aspart of rights issue	42944533
Totalproceeds received frompublic issue (in Rs. Crore)	85.89
Details of expenses incurred related to public issue (in Rs. Crore)	3.99*
Netproceeds available for utilization (in Rs. Crore)	81.90

*As per the letter of offer, the estimated issue related expenses were Rs. 4.49 crores out of which company has incurred Rs. 3.99 crores till December 2022. Further, the amount mentioned as expenses is the actual expenses which the company has paid for rights issue related expenses.

3) Details of the arrangement made to ensure the monitoring of issue proceeds:

==> picture [539 x 206] intentionally omitted <==

----- Start of picture text -----

Source of information / Comments of Comments
certifications considered the of the
Particulars Reply
by Monitoring Agency for Monitoring Board of
preparation of report Agency Directors
Whether all utilization is as per the disclosures in the Chartered Accountant
Offer Document? Yes certificate, Bank statement Not applicable
Whether shareholder approval has been obtained in
case of material deviations# from expenditures Not applicable Not applicable Not applicable
disclosed in the Offer Document?
Whether the means of finance for the disclosed
No Not applicable Not applicable
objects of the issue have changed?
Is there any major deviation observed over the earlier
Not applicable Not applicable Not applicable
monitoring agency reports?
Whether all Government/statutory approvals related to
Not applicable Not applicable Not applicable
the object(s) have been obtained?
Whether all arrangements pertaining to technical
Not applicable Not applicable Not applicable
assistance/collaboration are in operation?
Are there any favorable/unfavorable events affecting
No Not Applicable No
the viability of these object(s)?
Is there any other relevant information that may
No Not applicable No
materially affect the decision making of the investors?
----- End of picture text -----*

Where material deviation may be defined to mean:

a) Deviation in the objects or purposes for which the funds have been raised

b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents.

CARE Ratings Limited

E-1, 13th Floor, Videocon Tower, Jhandewalan Extension, New Delhi 110055 Phone: +91-011-4533 3200 / 238

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email:

CIN-L67190MH1993PLC071691

4) Details of objects to be monitored:

(i) Cost of objects

==> picture [556 x 320] intentionally omitted <==

----- Start of picture text -----

Source of Comments of the Board of Directors
information / Original
certifications cost Revised Comments
Propose Particulars of -
Sr. Item considered by (as per the Cost of the Reason
d firm
No Head Monitoring Offer in Rs. Monitoring for cost
financin arrangements
Agency for Document) Crore Agency revision
g option made
preparation of in Rs. Crore
report
Chartered
Accountant
Product
1 certificate, Bank 37.50 NA NA
Development
statements, Offer
Document
Chartered
Accountant
2 Product Marketing certificate, Bank 31.00 NA NA
statements, Offer
Document
Chartered
Accountant
Identified
3 certificate, Bank 156.70 NA NA
Investments
statements, Offer
Document
Chartered
Funding Inorganic
Accountant
growth initiatives
4. certificate, Bank 113.87 NA NA
and general
statements, Offer
corporate purposes
Document
Total 339.07
----- End of picture text -----

CARE Ratings Limited

E-1, 13th Floor, Videocon Tower, Jhandewalan Extension, New 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Delhi 110055 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-011-4533 3200 / 238 Phone: +91-22-6754 3456 Email:

==> picture [124 x 173] intentionally omitted <==

CIN-L67190MH1993PLC071691

==> picture [554 x 448] intentionally omitted <==

----- Start of picture text -----

(ii) Progress in the objects
Source of Amount utilised in Rs. Comments of the
information Amount Crore Board of Directors
/ as At
As at Unutilise
Sr certifications proposed the
. Item considered in the beginni During end d Comments of
N Head by Offer ng of the of the amount the Monitoring Reasons Proposed
the quarter in Rs. Agency for idle course of
o Monitoring Document quart
quarter in Rs. crore funds action
Agency for in Rs. er in
in Rs. Crore^
preparation Crore Rs.
Crore
of report Crore
During Q3FY23,
Chartered
company has paid
Accountant
Rs. 1.61 crores for
certificate,
Product product
1 Bank 37.50 0.80 1.61 2.41 35.09
Development development to
statements,
Robosoft
Offer
Technologies
Document
Private Limited
Chartered
Accountant
certificate,
2 Product Bank 31.00 - 0 - 31.00 NA
Marketing
statements,
Offer
Document
Chartered
The company
Accountant
given loan of Rs.
certificate,
Identified 2.20 crores to
3 Bank 156.70 45.11 2.20 47.31 109.39
Investments Helloworld
statements,
Technologies India
Offer
Private Limited
Document
The company has
acquired 100%
stake in a company
Funding Chartered
named Blink
Inorganic Accountant
Advisory Services
growth certificate,
4 initiatives and Bank 113.87 - 18.50 18.50 95.37 Private Limited
during Q3FY23 and
general statements,
subsequently
corporate Offer
changed the name
purposes Document
of company to
Aurum Analytica
Private Limited.
Total 339.07@ 45.91 22.31 68.22 270.85^
----- End of picture text -----

==> picture [489 x 64] intentionally omitted <==

CARE Ratings Limited

==> picture [124 x 173] intentionally omitted <==

E-1, 13th Floor, Videocon Tower, Jhandewalan Extension, New 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Delhi 110055 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-011-4533 3200 / 238 Phone: +91-22-6754 3456 Email:

CIN-L67190MH1993PLC071691

(iii) Deployment of un-utilized public issue proceeds:

==> picture [504 x 91] intentionally omitted <==

----- Start of picture text -----

Source of information / certifications
Sr. Name of the Amount in
Type of account considered by Monitoring Agency for
No. Bank Rs. crore
preparation of report
ICICI Bank Chartered Accountant certificate, Bank
1 Rights Issue Allotment account 0.82
statements
ICICI Bank Chartered Accountant certificate, Bank
2 Monitoring Account 3.39
statements
Total 4.21
----- End of picture text -----

Sr. No.	Type of instrument and name of the entity invested in	Amount invested	Maturity date	Earning	Return on Investment (%)	Market Value as at the end of quarter*
1.	Fixed Deposit (ICICI Bank)	10.00	January 1, 2023	0.01	5.25%	10.01

(iv) Delay in implementation of the object(s): Not applicable

5) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document: Nil as on December 31, 2022

CARE Ratings Limited

==> picture [124 x 173] intentionally omitted <==

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email:

E-1, 13th Floor, Videocon Tower, Jhandewalan Extension, New Delhi 110055 Phone: +91-011-4533 3200 / 238

CIN-L67190MH1993PLC071691